CLDX Gross Profit Growth
Celldex Therapeutics Inc · Gross Profit Growth
CLDX Gross Profit Growth
Year-over-year change vs the same period a year earlier
Latest reported56.71%period ending
CLDX TTM Gross Profit YoY % (336.36% → 56.71%)
Year-over-year change
High-resolution chart · PNG
CLDX gross profit growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Gross Profit Growth |
|---|---|
| 56.7148% | |
| -27.4403% | |
| -314.04% | |
| -149.6247% | |
| -501.3204% | |
| -76.2944% | |
| 47.4741% | |
| 7.002% | |
| 74.049% | |
| 41.3078% | |
| 3.1802% | |
| 0.8333% | |
| -44.5842% | |
| -66.0561% | |
| -64.206% | |
| -78.1443% | |
| -73.4405% | |
| -40.1268% | |
| -38.5665% | |
| -7.9809% | |
| 2.2163% | |
| 0.4069% | |
| 10.187% | |
| 0.4253% | |
| 0.1792% | |
| 19.8428% | |
| 30.0705% | |
| 43.5511% | |
| 48.2998% | |
| 37.8625% | |
| 32.9817% | |
| -9.6349% | |
| 17.4185% | |
| 34.3281% | |
| 41.6408% | |
| 13.0434% | |
| -286.3775% | |
| -169.5932% | |
| -149.3038% | |
| -137.1836% | |
| -47.811% | |
| 6,528.4733% | |
| 394.9784% | |
| 311.6646% | |
| 299.6813% | |
| -2,946.5116% | |
| -507.0523% | |
| -317.0754% | |
| -300.7782% | |
| -120.5251% | |
| 5,542.0561% | |
| 10,053.9216% | |
| 6,585.2601% | |
| 89.5928% | |
| 193.1507% | |
| -98.6835% | |
| -98.9233% | |
| -99.3372% | |
| -99.5794% | |
| 23,557.2519% | |
| 981.656% | |
| 651.4988% | |
| 411.8356% | |
| -99.0249% | |
| -74.7431% | |
| -59.8089% | |
| -9.025% | |
| 20.5404% | |
| 17.8784% | |
| 22.2993% | |
| 46.1025% | |
| 1,032.3454% | |
| 587.2637% | |
| 453.7307% | |
| 776.2034% | |
| -242.8989% | |
| -252.3921% | |
| -272.943% | |
| -81.1423% | |
| -82.7915% | |
| -70.416% | |
| -69.2491% | |
| -54.9713% | |
| -8.4322% | |
| -33.1625% | |
| -31.273% | |
| 48.0412% | |
| 15.7679% | |
| -4.5556% | |
| 4.7028% | |
| -30.4766% | |
| -32.3484% | |
| 141.7388% | |
| 112.5355% | |
| 72.924% | |
| 98.7306% | |
| -2.1037% | |
| 25.1646% | |
| 165.3081% | |
| 220.0413% |